{
    "2021-07-19": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：海外疫情反复 行业超跌后迎来反弹",
                "features": {
                    "keywords": [
                        "医药生物",
                        "海外疫情",
                        "反复",
                        "超跌",
                        "反弹"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：埃克替尼前期已开展了联合化疗用于敏感性EGFR突变晚期肺腺癌患者一线治疗的临床研究",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "埃克替尼",
                        "联合化疗",
                        "EGFR突变",
                        "晚期肺腺癌",
                        "临床研究"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}